Celltrion Plans $503M Investment in US Biopharma Manufacturing Facility, Driving Biosimilars Market Expansion

July 19, 2026

Data Bridge Market Research India

Overview

This article provides an overview of a market research report published by Data Bridge Market Research. According to the Data Bridge Market Research report, the biosimilars manufacturing market is experiencing significant growth, particularly highlighted by Celltrion’s announced plan to invest 700 billion won (approximately USD 503 million) for the acquisition of a biopharmaceutical manufacturing facility in the U.S. This exemplifies the substantial capital investment activities within the market. The Asia-Pacific region is projected to witness the fastest growth in the biosimilars manufacturing market, driven by expanding biomanufacturing capabilities in China, India, and South Korea.

In Depth

Key Findings

This article provides an overview of a market research report published by Data Bridge Market Research.

Report Overview

Data Bridge Market Research has released its latest report on the ‘Biosimilars Manufacturing Market.’ This report offers a detailed analysis of global and regional market size, growth trends, market share, and key player strategies from 2026 to 2033. It specifically focuses on the expanding pipeline of biosimilars, increasing approvals, and their contribution to improving global healthcare access.

Key Research Findings

The global biosimilars manufacturing market continues its robust growth, driven by the increasing number of biologics reaching patent expiry and the rising demand for more affordable and accessible treatment options.
Biosimilar manufacturing necessitates advanced technology and large-scale production capacities, characterizing the industry with substantial capital investments. Celltrion, a leading South Korean biopharmaceutical company, announced plans to invest approximately 700 billion won (approximately 503 million USD) to acquire a biopharmaceutical manufacturing facility in the United States. This investment aims to strengthen its presence in the North American market and secure manufacturing capacity to meet increasing demand.
Geographically, the Asia-Pacific region is projected to experience the fastest growth in the biosimilars manufacturing market. This is attributed to the rapid expansion of biomanufacturing capabilities in countries such as China, India, and South Korea, coupled with increased government support and investments from major CDMOs.
Reducing manufacturing costs, streamlining processes, and adopting single-use technologies are identified as key market trends.

About the Publisher

Data Bridge Market Research is a global market research and consulting firm that provides market reports across diverse industries. The company combines quantitative and qualitative analysis to offer deep insights and strategic advice, enabling clients to make informed decisions.

Source: https://www.databridgemarketresearch.com/reports/global-biosimilars-manufacturing-market

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.